Literature DB >> 24866785

Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action.

Paolo Gubellini1, Christophe Melon2, Elena Dale3, Dario Doller3, Lydia Kerkerian-Le Goff2.   

Abstract

Metabotropic glutamate 4 (mGlu4) receptor is a promising target for the treatment of motor deficits in Parkinson's disease (PD). This is due in part to its localization at key basal ganglia (BG) synapses that become hyperactive in this pathology, particularly striatopallidal synapses. In this context, mGlu4 receptor activation using either orthosteric agonists or positive allosteric modulators (PAMs) improves motor symptoms in rodent PD models in certain conditions. However, literature data show that mGlu4 receptor PAMs have no effect at striatopallidal GABAergic synapses (unless combined with an orthosteric agonist) and on the firing activity of pallidal neurons, and fail to provide significant motor improvement in relevant PD models. This questions the mechanistic hypothesis that mGlu4 receptor PAMs should act at striatopallidal synapses to alleviate PD motor symptoms. To shed light on this issue, we performed brain slice electrophysiology experiments. We show that Lu AF21934, an mGlu4 PAM small-molecule probe-compound, was ineffective at striatopallidal synapses at all concentrations tested, while it significantly inhibited corticostriatal synaptic transmission. Similarly, Lu AF21934 did not affect electrophysiology readouts at striatopallidal synapses in the presence of haloperidol or in 6-hydroxydopamine-lesioned rats. Interestingly, co-application of Lu AF21934 with a glutamate transporter inhibitor revealed a significant inhibitory action at striatopallidal synapses. Possibly, this effect could rely on increased level/permanence of glutamate in the synaptic cleft. Such differential efficacy of mGlu4 receptor PAMs at corticostriatal vs. striatopallidal synapses raises several issues regarding the synaptic target(s) of these drugs in the BG, and challenges the mechanisms by which they alleviate motor deficits in experimental PD models.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Basal ganglia; Electrophysiology; Globus pallidus; Lu AF21934; Rat; Striatum

Mesh:

Substances:

Year:  2014        PMID: 24866785     DOI: 10.1016/j.neuropharm.2014.05.025

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

Review 1.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

Review 2.  The external globus pallidus: progress and perspectives.

Authors:  Daniel J Hegeman; Ellie S Hong; Vivian M Hernández; C Savio Chan
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

3.  Co-operative binding assay for the characterization of mGlu4 allosteric modulators.

Authors:  Pekka Poutiainen; Kun-Eek Kil; Zhaoda Zhang; Darshini Kuruppu; Bakhos Tannous; Anna-Liisa Brownell
Journal:  Neuropharmacology       Date:  2015-05-27       Impact factor: 5.250

4.  Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.

Authors:  Colleen M Niswender; Carrie K Jones; Xin Lin; Michael Bubser; Analisa Thompson Gray; Anna L Blobaum; Darren W Engers; Alice L Rodriguez; Matthew T Loch; J Scott Daniels; Craig W Lindsley; Corey R Hopkins; Jonathan A Javitch; P Jeffrey Conn
Journal:  ACS Chem Neurosci       Date:  2016-08-05       Impact factor: 4.418

5.  mGluR4-containing corticostriatal terminals: synaptic interactions with direct and indirect pathway neurons in mice.

Authors:  Liliya Iskhakova; Yoland Smith
Journal:  Brain Struct Funct       Date:  2016-01-30       Impact factor: 3.270

6.  A nanobody activating metabotropic glutamate receptor 4 discriminates between homo- and heterodimers.

Authors:  Jordi Haubrich; Joan Font; Robert B Quast; Anne Goupil-Lamy; Pauline Scholler; Damien Nevoltris; Francine Acher; Patrick Chames; Philippe Rondard; Laurent Prézeau; Jean-Philippe Pin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

7.  Selective and interactive effects of D2 receptor antagonism and positive allosteric mGluR4 modulation on waiting impulsivity.

Authors:  Sarah N Isherwood; Trevor W Robbins; Janet R Nicholson; Jeffrey W Dalley; Anton Pekcec
Journal:  Neuropharmacology       Date:  2017-05-06       Impact factor: 5.250

Review 8.  The Modulation of Pain by Metabotropic Glutamate Receptors 7 and 8 in the Dorsal Striatum.

Authors:  Serena Boccella; Ida Marabese; Francesca Guida; Livio Luongo; Sabatino Maione; Enza Palazzo
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.